A phase ii study on the effect of taurisolo® administered via aerosol in hospitalized patients with mild to moderate covid-19 pneumonia: the taerovid-19 study

HIGHLIGHTS

SUMMARY

    The SARS-CoV-2-related epidemic, firstly reported in December 2019 in Wuhan, China, rapidly spread worldwide, becoming a pandemic, as defined by the World Health Organization (WHO) in March 2020. There are several measurements to make this risk negligible: (i) aerial isolation of the patient being treated and use of personal protective equipment as required by current recommendations on hospitalized patients; (ii) use of CPAP masks that reduce the dispersion of exhaled material. In fact, this trial demonstrated that, even if in a small group of patients, topic administration of this drug via . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?